Proposal for a standardized pathology report of gastroenteropancreatic neuroendocrine tumors: Prognostic significance of pathological parameters

Korean Journal of Pathology

Volumn 47, Issue 3, 2013, Pages 227-237

  Cho, Mee Yon ^a   Sohn, Jin Hee ^b   Jin, So Young ^c   Kim, Hyunki ^d   Jung, Eun Sun ^e   Kim, Mi Jung ^f,n   Kim, Kyoung Mee ^b   Kim, Woo Ho ^g   Kim, Joon Mee ^h   Kang, Yun Kyung ⁱ   Choi, Joon Hyuk ^j   Kang, Dae Young ^k   Kim, Youn Wha ^l   Choi, Eun Hee ^m  

^a Wonju Severance Christian Hospital   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c Soonchunhyang University College of Medicine   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

^e The Catholic University of Korea   (South Korea)

^f University of Ulsan College of Medicine   (South Korea)

^g Seoul National University Hospital   (South Korea)

^h Inha University Hospital   (South Korea)

ⁱ Inje University College of Medicine   (South Korea)

^j Yeungnam University Hospital   (South Korea)

^k Chungnam National University College of Medicine   (South Korea)

^l Kyung Hee University College of Medicine   (South Korea)

^m Yonsei University Wonju College of Medicine   (South Korea)

ⁿ Daehang Hospital   (South Korea)

more..

Author keywords

Digestive system; Grading; Neuroendocrine tumors; Pathology; Prognosis; Staging

Indexed keywords

EID: 84882636077     PISSN: 17381843     EISSN: None     Source Type: Journal    
DOI: 10.4132/KoreanJPathol.2013.47.3.227     Document Type: Article

References (28)

1. Gastrointestinal Pathology Study Group of Korean Society of Pathologists, Cho MY, Kim JM, et al. Current trends of the incidence and pathological diagnosis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Korea 2000-2009: multicenter study. Cancer Res Treat 2012; 44: 157-65.
2. Klöppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci 2004; 1014: 13-27.
3. Rindi G, Wiedenmann B. Neuroendocrine neoplasms of the gut and pancreas: new insights. Nat Rev Endocrinol 2012; 8: 54-64.
4. Williams ED, Siebenmann RE, Sobin LH. Histological typing of endocrine tumours. Geneva: World Health Organization, 1980.
5. Solcia E, Klöppel G, Sobin LH. World Health Organization international histological classification of tumours: histological typing of endocrine tumors. Berlin: Springer, 2000; 56-68.
6. Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. 4th ed. Lyon: IARC Press, 2010.
7. Klöppel G, Rindi G, Anlauf M, Perren A, Komminoth P. Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. Virchows Arch 2007; 451 Suppl 1: S9-27.
8. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 2010; 17: 1471-4.
9. Kloppel G. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. Endocr Relat Cancer 2011; 18 Suppl 1: S1-16.
10. Remes SM, Tuominen VJ, Helin H, Isola J, Arola J. Grading of neuroendocrine tumors with Ki-67 requires high-quality assessment practices. Am J Surg Pathol 2012; 36: 1359-63.
11. Klimstra DS, Modlin IR, Adsay NV, et al. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set. Am J Surg Pathol 2010; 34: 300-13.
12. Klöppel G, Couvelard A, Perren A, et al. ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology 2009; 90: 162-6.
13. Anthony LB, Strosberg JR, Klimstra DS, et al. The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum. Pancreas 2010; 39: 767-74.
14. Boudreaux JP, Klimstra DS, Hassan MM, et al. The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum. Pancreas 2010; 39: 753-66.
15. Volante M, Righi L, Berruti A, Rindi G, Papotti M. The pathological diagnosis of neuroendocrine tumors: common questions and tentative answers. Virchows Arch 2011; 458: 393-402.
16. Washington MK, Tang LH, Berlin J, et al. Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the colon and rectum. Arch Pathol Lab Med 2010; 134: 176-80.
17. Washington MK, Tang LH, Berlin J, et al. Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the stomach. Arch Pathol Lab Med 2010; 134: 187-91.
18. Washington MK, Tang LH, Berlin J, et al. Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the small intestine and ampulla. Arch Pathol Lab Med 2010; 134: 181-6.
19. Washington MK, Tang LH, Berlin J, et al. Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the appendix. Arch Pathol Lab Med 2010; 134: 171-5.
20. Kulke MH, Anthony LB, Bushnell DL, et al. NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas 2010; 39: 735-52.
21. La Rosa S, Klersy C, Uccella S, et al. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum Pathol 2009; 40: 30-40.
22. Rindi G, Klöppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006; 449: 395-401.
23. Volante M, Rindi G, Papotti M. The grey zone between pure (neuro)endocrine and non-(neuro)endocrine tumours: a comment on concepts and classification of mixed exocrine-endocrine neoplasms. Virchows Arch 2006; 449: 499-506.
24. Tang LH, Shia J, Vakiani E, Dhall D, Klimstra DS. High grade transformation of differentiated neuroendocrine neoplasms (NENs) of the enteropancreatic system: a unique entity distinct from de novo high grade neuroendocrine carcinoma (HGNECa) in pathogenesis and clinical behavior. Lab Invest 2008; 88(Suppl 1): 137A.
25. La Rosa S, Finzi G, Puppa G, Capella C. Lipid-rich variant of appendiceal well-differentiated endocrine tumor (carcinoid). Am J Clin Pathol 2010; 133: 809-14.
26. Soga J, Tazawa K. Pathologic analysis of carcinoids: histologic reevaluation of 62 cases. Cancer 1971; 28: 990-8.
27. Adsay V. Ki67 labeling index in neuroendocrine tumors of the gastrointestinal and pancreatobiliary tract: to count or not to count is not the question, but rather how to count. Am J Surg Pathol 2012; 36: 1743-6.
28. Rindi G, Falconi M, Klersy C, et al. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst 2012; 104: 764-77.